Hok Hei Tam
Senior Principal at Flagship Pioneering
Cambridge, Massachusetts
Overview
Work Experience
Senior Principal
2023 - Current
Principal
2021 - 2023
Senior Associate
2019 - 2021
Co-Founder of Senda Biosciences
Associate
2017 - 2019
Co-Founder of FL62 and FL65.
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
CTO
2019
Acting CTO
2020 - 2023
Invaio Sciences is a technology company that is dedicated to solving pressing agriculture, nutrition, and environmental challenges.
Raised $138,900,000.00 from K2 HealthVentures.
Scientific Consultant
2017 - 2017
Bioinformatics Consultant
2017 - 2017
PhD Candidate
2012 - 2017
Ph. D. in Chemical Engineering with a Minor in Machine Learning Advisor: Dr. Daniel Anderson Committee: Dr. Bob Langer and Dr. Angela Koehler At the Anderson Lab, I developed a vaccine dosing scheme that leads to >10-fold improvement in antibody production, leading to a first-author publication in the Proceedings of the National Academy of Science. I also created statistical methods and software to analyze the effects of novel materials on fibrosis, leading to 4 publications in top journals: Nature Medicine, Nature Biotechnology, and Nature Materials. Furthermore, I developed novel conjugates for siRNA delivery to various tumors, leading to a Best Paper in Section award at the largest Chemical Engineering conference (AIChE) and publications in preparation. Work in my Ph.D. has contributed to two venture-backed companies: Sigilon and Verseau Therapeutics.
Entrepreneurial Fellow
2017 - 2017
As an entrepreneurial fellow, I explored new areas of science to generate ideas for first-in-class life-sciences companies.
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Project Lead/Developer
2014 - 2017
The PCHR Lebanon project developed a portable patient-centric electronic health record system with decision support features that was deployed to 10 primary healthcare centers throughout Lebanon to assist in the treatment of Syrian refugees with chronic disease. It received a Research for Health in Humanitarian Crises grant from ELRHA. This project was also a finalist in the Applied Innovation Institute's University Mobile Challenge in 2015
Scientific Consultant
2016 - 2017
Scientific Consultant
2016 - 2016